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All mammalian cells exhibit circadian rhythm in cellular metabolism and energetics. Autonomous cellular clocks 
are modulated by various pathways that are essential for robust time keeping. In addition to the canonical 
transcriptional translational feedback loop, several new pathways of circadian timekeeping - non-transcriptional 
oscillations, post-translational modifications, epigenetics and cellular signaling in the circadian clock - have been 
identified. The physiology of circadian rhythm is expansive, and its link to the neurodegeneration is multifactorial. 
Circadian rhythm disruption is prevelant in contamporary society where light-noise, shift-work, and transmeridian 
travel are commonplace, and is also reported from the early stages of Alzheimer's disease (AD). Circadian 
alignment by bright light therapy in conjunction with chronobiotics is beneficial for treating sundowning 
syndrome and other cognitive symptoms in advanced AD patients. We performed a comprehensive analysis of 
the clinical and translational reports to review the physiology of the circadian clock, delineate its dysfunction in 
AD, and unravel the dynamics of the vicious cycle between two pathologies. The review delineates the role of 
putative targets like clock proteins PER, CLOCK, BMAL1, ROR, and clock-controlled proteins like AVP, SIRT1, 
FOXO, and PK2  towards future approaches for management of AD. Furthermore, the role of circadian rhythm 
disruption in aging is delineated.
Keywords: circadian rhythm coupling; redox; suprachiasmatic nuclei; sleep-wake cycle; post-translational 
modifications; aging
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1. Introduction
Life on earth has evolved with endogenous mechanisms of periodicity that allow organisms to adapt to the 
environment through anticipation [1]. Some simpler archaic oscillators are conserved across kingdoms and have 
integrated with complex timekeeping systems in multicellular organisms [2]. These biological rhythms account 
not only for subtle biochemical changes but govern our daily behavior, including the sleep-wake cycle, mood, and 
attention. Circadian (Latin: about a day) rhythms are the most widely studied form of biological rhythms that 
oscillate every 24 hr. Humans have a free-running circadian period of 24.18 hr. [3], which is entrained and 
synchronized to the geophysical time exogenously through photic zeitgebers (German: time giver) [4]. Photic 
entrainment mitigates slight aberrations in the circadian clock. However, the ramifications of chronic disruptions 
are severe. Circadian rhythms may be disrupted endogenously by genetic mutations or exogenously through 
mistimed environmental cues.
Alzheimer's disease (AD) is characterized by progressive loss of memory and other cognitive functions that 
severely impact the patients’ social skills and ability to perform a routine task. Presence of amyloid plaques, 
hyperphosphorylated tau protein in the patients’ brains are the hallmarks of AD. More than 50 million people 
globally are living with dementia, and AD accounts for 70 % of the cases. This figure is predicted to double every 
twenty years [5]. The rising numbers stem from a dire lack of effective treatment. Therefore, it is crucial to identify 
and understand contributing factors to the AD pathology, which may be modified to manage and slow its 
progression at the early stages.  Circadian rhythm disruption (CRd) is observed in Alzheimer’s patients from the 
early stages of the disease [6-8]. Moreover, postmortem analysis of the brains confirms morphological changes 
in the core machinery of the central circadian clock [9]. The clinical evidence of CRd and AD association is 
overwhelming. However, whether CRd is a cause or the consequence of AD is not fully understood. 
Here, we review the published literature from clinical and translational studies and discuss in succession all 
features of the clock machinery and their dysfunction in AD.


































































2.1.  Circuitry of the master-clock in health and AD
All mammalian cells in brain and periphery contain an autonomous circadian clock that is modulated by various 
pathways for robust time keeping. Autonomous circadian clocks are coupled and entrained by the suprachiasmatic 
nuclei (SCN) located bilaterally in the ventromedial hypothalamus, also known as the master-clock [10]. A human 
SCN contains ca. 50,000 neurons constituting the core and the shell sub-nuclei. A light stimulus (photic cue) is 
transmitted to the core of SCN via glutamate signaling through the retinohypothalamic tract (RHT). In contrast, 
serotonergic signaling occurs through the raphe nuclei and cholinergic signaling through the basal forebrain and 
pons transmit non-photic cues [11, 12]. Melanopsin-containing retinal ganglion cells (mRGCs) are a class of 
retinal photoreceptors that regulate the circadian photoentrainment of the master clock [13]. Six types of mRGCs 
have been identified, depending on the location of their dendritic arborization in the inner plexiform layer. mRGCs 
are an essential component for the SCN photoentrainment, and its deterioration has been directly associated with 
circadian rhythm disruption [14]. mRGCs signaling not only entrains the circadian system, but also modulate 
mood and memory through the SCN and other pathways independent of the circadian system [15, 16].  The 
mRGCs activate glutamatergic neurons in the RHT, that further entrain and induce a robust expression of 
immediate early genes (IEG) in the SCN (described in Section 3.2). Subsequently, SCN entrains other brain 
structures and peripheral clocks through humoral signaling and thus maintains an adaptive phase control over all 
autonomous clocks [17]. 
A network of efferent circuits extends from the SCN to sub-paraventricular zone (sPVZ), dorsomedial 
hypothalamus (DMH), thalamus, lateral septum, stria-terminalis, and intergeniculate nuclei. The human SCN is 
connected to thirty-five brain regions through direct neuronal projection and eighty-five regions through 
multisynaptic connections [18]. The resting potential of the SCN is high (-50mV) in the daytime, and it vigorously 
activates other brain areas. In contrast, the neural activity is relatively low (-60mV) at night [19]. SCN ablation 
in the hamsters and its subsequent transplantation efficaciously recapitulates their circadian rhythm of locomotor 
activity. Since this effect is achieved regardless of the SCN orientation, it implies a primary role of the diffusible 
signaling molecules like prokineticin 2 (PK2), arginine vasopressin (AVP) and vasoactive intestinal polypeptide 
(VIP) in the entrainment [20]. VIP cells are abundant in the ventrolateral core and AVP cells in the dorsomedial 
shell of the SCN, and these molecules play an inextricable role in the communication within and outward from 
the SCN. Retinorecipient neurons in the SCN express VIP and play a crucial role in resetting the circadian clock 
[21]. Furthermore, PK2 receptor 2 (Prokr2) is essential for SCN mediated neuronal activation in the cortex and 
hippocampus, although it is not required for the intracellular timekeeping [22]. SCN organizes circadian rhythms 
in a scale-invariant manner. This essential factor allows organisms to smoothly transition through the seasonal 
changes in light-dark cycles [23]. A clock gene period 2 (Per2) also acts as an IEG and responds to photic zeitgeber 
(described in Section 3.2), which adds a calendar role to the circadian clock by daily photic remodeling [24]. 
AD patients exhibit dampened and delayed rhythms of the locomotor activity and core body temperature [7]. 
Circadian rhythm in the SCN of rats shows shortening of free-running period which leads to amplitude dampening 
and phase advances of some peripheral tissues relative to light/dark cycleCircadian rhythm becomes dampened 
and aperiodic to geophysical time in normal aging due to the inability of the SCN to synchronize peripheral 

































































rhythms  [25]. However, the amplitude decrease is highly significant, and the circadian phase is commonly 
delayed in AD patients [8]. These physiological changes can be explained by examining the morphology and 
mediators of the circadian system, which are severely affected in AD brains. There is a significant reduction of 
retinal nerve fiber layer, loss of optic nerve axons and the mRGCs are severely affected by Aβ aggregation in the 
flat-mounted AD retinas [26]. The authors of the study concluded that mRGC degeneration is a contributor to 
circadian misalignment in AD patients. Furthermore, there is a significant decrease in the neuronal density and 
volume of the SCN in AD patients compared to the age-matched controls [9]. AD patients also exhibit diminished 
expression of neuroprotective peptides (AVP and neurotensin) in the SCN that is supplemented by an increased 
astrocyte-to-neuron ratio [27]. The decrease in protein levels of the AVP is paralleled by a decrease in its mRNA 
expression in the SCN of AD patients [28]. In addition, the pre-AD pathologic triple-transgenic AD mice (3xTg-
AD) express a significantly reduced number of AVP and VIP secreting neurons in the SCN [29]. It implies that 
the dysfunction in the AVP and VIP signaling precedes AD pathology, though the responsible molecular pathways 
remain elusive. 
Another SCN output molecule PK2 acts as an endangering mediator for cerebral damage and plays a critical role 
in neuronal autoimmunity [30]. Exogenous administration of Aβ42 increases the mRNA levels of Pk2 and its 
receptor Prokr2 in the hippocampus of mice in a time-dependent manner. Furthermore, PC1 (a Prokr2 antagonist) 
ameliorates long term potentiation impairments in Tg2576 AD mice and suppresses the Aβ42 induced toxicity in 
cultured neurons of mice [31]. PK2 acts as an interface and mediates Aβ42 induced toxicity through the 
glutamatergic system by activating the AMPA receptors [32]. Although this group shows a piece of compelling 
evidence for the relationship of PK2 system and Aβ toxicity in AD, the chosen model is relevant to the post-
amyloid-pathologic stages of AD. There is a lack of evidence for the role of PK2 signaling in AD preceding the 
amyloid pathology.
2.2. Transcriptional cog in health and AD
Nucleated cells display a transcription-translation feedback loop (TTFL) among the clock genes, the first cog in 
the circadian clock. Core clock genes viz. circadian locomotor output cycles kaput (Clock), brain and muscle 
ARNT-like 1 (Bmal1), period (Per 1, 2 & 3) and cryptochrome (Cry 1 & 2) form the TTFL (Fig 1), however, 
there are 14 representative clock genes [33]. Npas2 (a Clock paralog) dominates extra-SCN areas of the 
mammalian brain [34]. Briefly, Clock and Bmal1 genes constitute the positive limb, and Per and Cry genes 
constitute the negative limb of the TTFL. CLOCK: BMAL1 dimer acts as a transcription factor that promotes the 
E-box dependent transcription of Per and Cry genes, which are later translated into repressor proteins, PER and 
CRY [35]. Three isoforms of PER (1, 2 & 3); and two isoforms of CRY (1 & 2) differentially regulate the positive 
limb by influencing the CLOCK and BMAL1 associations [36, 37]. Finally, the repressor proteins are degraded 
by post-translational modifications that disinhibit the positive limb. 
The post-translational modifications of the repressor proteins are an essential step in maintaining the circadian 
period (detailed in Section 3.1) [38, 39]. CLOCK: BMAL1 dimer also induces the transcription of retinoic acid-
related orphan receptor alpha (Rorα) and Rev-erbα genes. Subsequently, RORs activate, and REV-ERBs repress 
the transcription of Bmal1 gene [35]. Additionally, core clock genes transcribe up to 10% of the total genes 

































































expressed in mammals, known as the clock-controlled genes (CCG) [33] (Fig 1).  CCGs are translated into various 
proteins, intracellular enzymes and hormones that impart the influence of circadian clock over other biological 
systems and overall physiology of the organism. RNAseq and DNA-array of mice reveal that 43% of the coding-
RNA genes, as well as more than a thousand of the conserved non-coding-RNA genes, exhibit oscillatory 
transcriptions in an organ-specific manner [40]. 
AD patients display an out-of-phase expression of Bmal1 and Per2 mRNAs (compared to the age-matched 
controls) in the cingulate cortex and other brain areas implicated in motivated behavior and decision making [41]. 
Additionally, single-nucleotide polymorphism of the Clock and Bmal1 genes have been associated with a high 
risk of AD in the Chinese population [42-45], although more studies are required to corroborate these findings. 
APPxPS1 transgenic mice show diminished expression of Per2 in the hypothalamus and hippocampus [46], which 
is a sign of disrupted autonomous clocks. Furthermore, PER2 regulates the cellular response to oxidative stress 
by influencing the Bcl-2 gene transcription. Embryonic fibroblasts from Per2 mutant mice are more resistant to 
oxidative stress-induced cell death compared to the wild-type [47]. In contrast, deletion of Per gene in 
neurodegeneration-prone, carbonyl-reductase mutant Drosophila accelerates the symptoms of neurodegeneration 
and symptoms of aging [48]. This suggests that the optimal oscillatory expression of Per2 at the tissue level is 
requisite for normal neurophysiology. 
Furthermore, the deletion of Bmal1, the primary driving force of the TTFL, disrupts the sleep-wake cycles and 
renders the central TTFL arrhythmic in mice [49]. Contrarily, the sleep deprivation and mistimed light exposure 
can also repress the expression of BMAL1 in mice l ading to ineffective binding of CLOCK: BMAL1 dimer to 
the chromatin [50, 51]. Furthermore, Bmal1 deletion in mice results in the development of AD-like pathology, 
marked by the cortical and hippocampal astrogliosis [52], and memory impairment [53]. Conversely, a 
pathological concentration of Aβ42 facilitates BMAL1 degradation [54] resulting in circadian dysfunction. The 
literature suggest that the associations between the circadian rhythms disruption (CRd) and AD pathology is 
bilateral, and a vicious loop is formed between the two pathologies, Fig 3; however, what sets the loop into action 
is not yet known. A possible solution is examining the autonomous clocks by single-cell analyses. Interestingly, 
recent research found that Aβ42 expression in glia, but not neurons of the SCN disrupts the central circadian clock 
in Drosophila, which may provide some clarity to the mechanism of AD-induced-CRd [55]. However, a clear 
picture of CRd-induced-AD is still a work in progress.
2.3.  Non-transcriptional or metabolic cog in health and AD
Rhythmic processes of intracellular reactive oxygen species (ROS) production manifest as redox oscillations, the 
second cog in the circadian clock. The marker of redox oscillations, peroxiredoxin 1 (PRX1), a thiol-dependent 
peroxidase is conserved through archaea which is speculated to have evolved after the Great Oxidation Event, 2.5 
billion years ago [2]. These oscillators are conserved across kingdoms and are also present in the primitive 
anucleated cells, and therefore do not require much-advanced transcription mechanisms [56, 57]. Six isoforms of 
peroxiredoxins are reported in mammals that localize in the cytosol (PRX 1, 2, 5 & 6), the mitochondria (PRX 3 
& 5) and the endoplasmic reticulum (PRX4) [58]. Oxidation of PRX (1 - 6) at the peroxidatic cysteine residue 
yields disulphide-PRX that is recycled by thioredoxins known as the fast loop. Alternatively, PRX may enter an 

































































over- or hyper-oxidized (PRX-SO2/3) state. Sulfiredoxin sluggishly recycles the PRX-SO2, known as the slow 
loop. However, its transition to hyper-oxidized PRX-SO3 is non-reversible, and it serves as a non-peroxidatic 
chaperon (Fig 1) [59].
Selective deletion of 2-Cysteine-PRX dampens the amplitude of the PRX1 expression. However, the rhythms 
persist, possibly through compensation by the TTFL mechanism [2]. Furthermore, other antioxidant biomolecules 
such as glutathione and mRNA levels of catalase, superoxide dismutase, heme oxygenase-1, and cyclooxygenase-
2 also display a circadian rhythm [60, 61]. The rhythmic expression of these antioxidant proteins is abolished in 
Clock mutant Drosophila and mice [62, 63]. It represents a bidirectional interaction between redox oscillations 
and the TTFL (described in Section 4). Pentose phosphate pathway (PPP) has been recently implicated in the 
remodeling of both TTFL and the non-transcriptional oscillations. PPP is a critical source of NAD(P)H that impels 
the redox oscillation by regulating the oxidative states on PRX. Additionally, PPP remodels the TTFL by 
recruiting archetypal histone acetyltransferase P300 that inhibits the binding of BMAL1: CLOCK dimer to the 
DNA [64].
The association of PRX system with AD has been long registered; however, its role as a marker of the redox 
oscillations has recently become evident. Post-mortem analysis of AD brains shows an elevation in levels of 
cytosolic PRX (1 & 2) and a reduction in levels of mitochondrial PRX3 [65]. The reduced levels of PRX3 signify 
a compensatory response to oxidative damage. Furthermore, total levels of oxidatively-modified PRX are altered 
in the erythrocytes of AD patients in a way that is distinguishable from vascular dementia patients [66]. The 
authors explored the credibility of oxidatively modified PRX(PRX-SO2/3) in the diagnosis of AD. The PRX 
proteins serve as a reliable indicator of oxidative stress in the cell. The oscillating levels of oxidized PRX imply 
an oscillation in metabolic activity and energy expenditure in the cell. It is widely accepted that oxidative stress 
plays a decisive role in the early stages of AD [66-69]. However, it may also have a crucial role in the onset of 
AD in healthy subjects. There is plenty evidence for the role of oxidative stress in the instigation of AD-specific 
pathological mechanism, for instance, processing/activity of APP and BACE1 and γ-secretase are profoundly 
influenced by the redox status of the cell [67-69]. Exogenous administration of Aβ42 in Prx6 knock-in mice 
accelerates memory loss; induces oxidative damage; induces astrogliosis; and upregulates APP, C99, BACE1 
[70]. The role and involvement of rhythmic nature of redox states in AD is still an area of active research. 
However, these studies suggest that the PRX dyshomeostasis acts an accelerant of AD pathology, whether this 
impairment also contributes to the initiation of the disease remains to be ascertained.
3. Regulation of the circadian clock
3.1.  Post-translational regulation of the clock in health and AD
Enzymatic modifications of the proteins by ubiquitination, phosphorylation or acetylation are essential for 
regulation of the clock proteins. Post-translational modifications of the clock proteins are a requisite for robust 
timekeeping in eukaryotes [71]. In mammals, two closely related isoforms of casein kinase 1 (CK1 δ and ε) are 
implicated in the modulation of circadian rhythms [72]. CK1 ε/δ phosphorylates and degrades the repressive clock 
protein PER [73]. Ralph and Menaker [74], in their pioneering work, reported that a mutation at the autosomal 
locus (tau) is associated with the shorter circadian period in tau hamsters. Subsequently, the responsible gene was 

































































identified to be Ck1, which whether expressed homo- or heterozygous abnormally shortens the circadian period 
due to differential degradation patterns of the PER proteins [75]. Another nuclear protein βTrCP also degrades 
PER2 by ubiquitination [76]. Furthermore, the circadian clock is stable across a range of temperature fluctuations, 
known as the ‘temperature compensation’ [77]. Temperature compensation is a phylogenetically conserved trait 
that is attributable to post-translational modifications of the clock proteins. Initially, it was proposed that CK1(ε 
and δ) are temperature insensitive kinases, and thus may be responsible for temperature compensation by its action 
on the phosphoswitch [78]. Finally, a more comprehensive representation of temperature sensitive phosphoswitch 
was proposed, based on two competing phosphorylation sites on PER2. The authors also report that 
phosphorylation of PER2 by CK1ε can be “switched off” by ubiquitination by βTrCP [79]. Furthermore, the post-
translational phosphorylation of CRY1 may also regulate the circadian clock. The ratio of active to phosphorylated 
CRY1 in a cell modifies its repressive activity on BMAL1: CLOCK and determines the circadian period [80]. 
Chromatin remodeling by histone modifications also alters the expression of clock controlled genes (CCG) [81]. 
Moreover, the mechanisms of histone modifications such as methylation, acetylation, and phosphorylation also 
exhibit a circadian rhythm [82]. Initial work indicated that the binding of CLOCK: BMAL1 dimer to E-box 
promoter regions on chromatin is associated with histone acetylation [83]. Subsequent studies revealed that 
CLOCK protein posseses acetyltransferase properties and: rhythmically acetylates histone H3 to expose promoter 
regions of the CCG; acetylates its partner BMAL1; and facilitates CRY dependent inhibition of the positive limb 
of TTFL [84, 85]. Conversely, Sirtuin 1 (SIRT1) is a class III histone deacetylase that counterbalances 
acetyltransferase activity of the CLOCK, and thereby indirectly regulates the circadian clock by regulating the the 
acetylation rates of H3 and BMAL1, and functions as an “enzymatic rheostat of circadian function” [86]. 
Biosynthesis of SIRT1, in turn, is controlled by the CLOCK: BMAL1 dimer. The dimer promotes the transcription 
nicotinamide phosphoribosyltransferase (Nampt) gene, that is translated to a crucial enzyme in the regulation of 
SIRT1 expression [87]. Furthermore, the expression of SIRT1 is regulated by both external and internal factors, 
such as diet, exercise, and intracellular oxidative stress [88]. While deeply integrated within the transcriptional 
and non-transcriptional cogs of the clock, SIRT1 also regulates the neuroimmunity by inhibiting the microglial 
activation of the transcription factor, NF-κB [89]. Furthermore, the clock protein REV-ERBα recruits SIRT1, and 
collectively modulate the transcription of lipid biosynthetic genes in the mammalian liver [90]. 
Ck1δ mRNA levels show a 24-fold increase in the hippocampus of AD brains, and its protein expression parallels 
the mRNA expression and colocalizes with senile plaques and tau deposits [91]. CK1δ targets more than fifteen 
sites on tau protein that are hyperphosphorylated in the insoluble paired-helical-filament tau extracted from AD 
brains [92]. Furthermore, there is a significant reduction in Sirt1 mRNA levels that negatively correlates with the 
duration of symptoms and the accumulation of tau in AD brains [93]. Acetylation of tau proteins by histone 
acetyltransferase p300 inhibits the proteasomal degradation of hyperphosphorylated tau. In contrast, deacetylation 
by Sirt1 promotes degradation of hyperphosphorylated tau. Therefore, deletion of Sirt1 upregulates the levels of 
acetylated tau, and hence contributes to tauopathy  [94]. Calorie restriction is also beneficial in preventing Aβ 
pathology. A 30% calorie restriction significantly reduces cortical Aβ42 concentration that negatively correlates 
with SIRT1 protein concentration in a primate model of AD [95]. The implication of these proteins in AD 
pathology further supports the conception that the association between CRd and AD is multifactorial and bi-
directional.

































































3.2.  Cellular signaling in the clock in health and AD
Cellular signaling in the circadian clock is a fast-growing area of basic research, primarily because these 
pharmacologically modifiable pathways and targets are relevant to the drug discovery prospects. Cellular 
signaling is at the core of circadian rhythm entrainment. Visual phototransduction (described in Section 2.1) 
through RHT stimulates post-synaptic n-methyl-d-aspartate receptors (NMDAr) in the SCN and activates the 
transcription factor cAMP response element-binding that induces the transcription of IEGs c-fos and Per2 [96]. 
SCN-specific deletion of NMDAr abolishes light-induced phase shifts in hamsters [97]. Since the clock gene Per2 
is also an IEG, its transcription is driven by the E-box as well as the CRE promoter (Fig 1). Therefore, the rhythmic 
expression of Per2 under normal light/dark conditions is unaffected by the SCN-specific deletion of Bmal1 or 
Cry (1 & 2). This indicates an essential role of cAMP/Ca2+ signaling in the circadian rhythms [98]. cAMP/Ca2+ 
signaling plays a fundamental role in maintaining the amplitude, phase, and period of the circadian rhythm. 
Pharmacological inhibition of cAMP signaling results in dampened peaks, phase resetting, and increased circadian 
period ( >31 hr.) [99]. cAMP/Ca2+ signaling is modulated bilaterally by light-driven glutamate bouts and TTFL-
driven protein dynamics [98]. Circadian resetting of post-synaptic SCN neurons through phototransduction relies 
on Ca2+ signaling, which opens a possibility that chronic or mistimed light may be capable of disrupting Ca2+ 
homeostasis within the cells.
A family of transcription factors - forkhead box-O class of transcription factors (FOXO) - is attracting a 
widespread interest as they may bridge the gap between the cellular signaling and the TTFL. FOXO proteins are 
regulated by ROS and insulin via JNK and PI3K pathways respectively and stimulate the transcription of various 
genes (including Clock) [100, 101]. Furthermore, FOXO3 stimulates the transcription of Sirt1 through a protein-
53-dependent, nutrient sensing pathway [102]. Other transcriptional targets of FOXO proteins are Nampt and 
autophagy-related gene 14 (Atg14), which are essential for the lipid metabolism and autophagy. Additionally, 
Nampt and Atg14 mRNA exhibit a circadian rhythm, and their genes contain promoter regions for both FOXO 
proteins and CLOCK: BMAL1 [103, 104]. The fact that these redox responsive genes are integrally regulated by 
FOXO proteins and CLOCK: BMAL1, shows an association between cellular signaling and the circadian clock, 
although the exact mechanism of this integration is still an area of active research.
Two-photon Ca2+ analysis of APP mice cortex reveals a significant calcium overload in the neurons proximal to 
the amyloid plaques, which results in distorted neuritic morphologies and a loss of spinodendritic calcium 
compartmentalization [105]. The hyperactive neurons in the proximity of plaques show an abnormal increase in 
the Ca2+ transients as a result of synaptic disinhibition [106]. Thus, it follows that plaque-surrounding-neurons of 
the SCN may exhibit hyperactivity due to the calcium currents. Since Ca2+ signaling plays essential role in 
circadian entrainment, we propose that Ca2+ dyshomeostasis caused by Aβ42 species may contribute to the 
circadian dysfunction observed in AD. The above discussed studies emphasize how Ca2+ dyshomeostasis 
progresses after the onset of AD. However, Ca2+ dyshomeostasis may also play a role in the progression of AD. 
High levels of cytosolic Ca2+ favors the amyloidogenic micro-processing of APP and thereby results in Aβ 
production in pathological proportions [107]. Additionally, the nuclear factor of activated T cells 1 (NFAT1), a 
transcription factor that binds the Bace1 promoter region is activated by high levels of intracellular Ca2+ 
concentrations [108]. Ca2+ also regulates the proteolytic activity of BACE1 by modifying the acidity of the 

































































cytosolic medium [109]. The above reviewed literature suggests that calcium dyshomeostasis and Aβ production 
characterizes a bi-directional relationship, and further demonstrates the existence of a vicious loop between AD 
pathology and CRd , Fig 3.
Aβ42 peptides are found to induce dephosphorylation and mitochondrial translocation of the FOXO3a, which 
promotes its association with the mitochondrial DNA [110]. Further, the study reports that FOXO3a induces 
mitochondrial damage as a downstream effect of cytochrome C oxidase subunit-1 gene downregulation. The 
authors of the study also report that Aβ42 associated mitochondrial damage can be suppressed by knocking out 
FOXO3a gene, implicating the role of FOXO in AD. However, this only represents one facet of the complex 
relationship between FOXO and AD, more studies are required to ascertain this relationship. 
4. Coupling of rhythms in health and AD
A plethora of physiological rhythms are coupled to maintain homeostasis. For example, a coordination between 
natural light-dark cycles, activity-rest periods, and feeding cycles is crucial for optimal orchestration of the 
circadian rhythms (Fig 2). At the molecular level in smaller organisms like Neurospora, a temporal relationship 
between the intracellular redox state and circadian system is indispensable for a robust circadian clock [111]. 
Light induced entrainment is fundamental to TTFL in the SCN as opposed to the food availability dependent 
entrainment of TTFL in the peripheral clocks. Therefore, forced feeding in mice uncouples their activity- and 
metabolic rhythms and has a deleterious effect on the molecular clock [112]. Furthermore, abrupt shifts in the 
light-dark cycle impede the SCN’s adaptive phase control on peripheral clocks [17]. Insulin resistance, 
hypertension, and inverted cortisol rhythms are the consequences of such uncoupling that leads to stress, 
metabolic- and cardiovascular disorders [113]. 
The synchronicity between TTFL and redox rhythms is essential for a robust circadian clock [114]. There is a 
cyclic relationship between TTFL and redox oscillations (Fig 2). The binding of CLOCK: BMAL1 to the E-box 
promoter region is pH sensitive and regulated by the ratio of oxidized to reduced NAD cofactors [115, 116]. 
Furthermore, redox rhythms expressed by the SCN influence its entrainment by modulating the neuronal 
excitability through membrane-bound K+ channels [117]. Redox system also imparts influence over the TTFL 
through its other elements. Redox cofactor flavin adenine dinucleotide plays a decisive role in stabilizing the 
repressor protein CRY [118]. Nuclear factor erythroid-derived 2-like 2 (NRF2) upregulates the transcription of 
Rev-erbα gene in oxidatively stressed conditions [119, 120]. TTFL, in turn, regulates the cellular redox status 
through the expression of CCG [121]. The transcription of the redox-sensing genes such as NAD(P)H 
dehydrogenase-quinone 1, aldehyde dehydrogenase 2, and Nrf2 is influenced by the activity of CLOCK and 
BMAL1 [52, 63]. Other feedback loops also exist within the circadian clock. The association between CLOCK: 
SIRT1 dimer and NAMPT controls the NAD+ salvage pathway through a transcriptional-enzymatic feedback 
loop [122]. A similar feedback loop is present within the interactions of CLOCK-SIRT1 and acetyl-CoA 
synthetase-1, a key regulator of post-translational modifications in histones [123].
CRd is the primary reason for the institutionalization of AD patients [6]. Circadian rhythms are uncoupled by 
mistimed light or feeding cycles, a common occurrence in chronic shift-work or repetitive transmeridian travel, 

































































which might have serious implications in AD pathogenesis. Oscillations in the clock gene expression are 
detectable in the post-mortem AD brains. However, their phases are desynchronized [41], thus highlighting the 
insufficiency of the SCN to synchronize the autonomous clocks. Cho and colleagues [124] found that levels of 
circulating cortisol were chronically elevated in the cabin-crew of transatlantic flights accompanied by spatial 
memory deficits and a significant reduction in hippocampal volume. As discussed before, the disrupted hormonal 
cycles could result from the loss of SCN’s adaptive phase control on peripheral clocks. A follow-up on 1,282 
earlier cognitively-normal elderly women revealed that dampened and delayed circadian rhythms significantly 
increases the odds of developing dementia compared to the age-matched controls [125]. 
In line with the clinical findings, mimicking jet-lag in mice shows memory impairment and faulty adult 
neurogenesis in the hippocampus, a key area involved in AD [126]. Cognition and memory are a result of 
coordinated activity within a network of neuronal pathways. The desynchronized circadian oscillations in the 
neurons may affect memory processing. The significance of circadian system in memory formation and processing 
is well reported. GABA output from the SCN influences hippocampus-dependent memory [127]. Furthermore, 
CRd due to exogenous factors such as mistimed light [126-129], and feeding time [130]; or endogenous factors 
such as genetic mutations [53], have been shown to significantly impair the memory performance of experimental 
animal. The memory loss and oxidative stress appear early and are more pronounced in the jetlagged transgenic 
AD mice (APPSwDI NOS2-/-) [131]. The presented elements of circadian clock and its regulatory mechanisms 
are found dysregulated and thereby reinforce the AD pathology, Table 1. Further studies aiming to modify 
functioning of the targets of circadian clock and its links to mediators like NADPH, SIRT1, NRF2, acetyl co-A 
and GABA could be a better way to investigate novel therapeutic strategies for ameliorating circadian 
misalignment in AD.
5. Sleep-wake cycles in health and AD
Sleep is a physiological requirement throughout the animal kingdom. However, the type and duration of sleep 
may vary among species. Pioneering research to understand the nature of sleep-wake cycles revealed a 
thalamocortical switch between arousal and inhibitory signals. Recent developments in the field reveal a 
prominent role of fast acting neurotransmitters glutamate and gamma-aminobutyric acid (GABA). The primary 
glutamatergic inputs from the parabrachial nucleus and pedunculopontine tegmental nucleus propagate the 
arousal, and GABAergic inputs from ventrolateral preoptic nucleus (VLPO), median preoptic, and parafacial zone 
promote sleep by inhibition of the arousal system [132]. The complex circuits of sleep are extensively reviewed 
elsewhere [133]. Interestingly, SCN plays a pivotal role in the sleep circuitry and determines “when” and “how 
much” of the sleep is required. Both the VLPO and lateral hypothalamus receive SCN inputs through sPVZ to 
DMH, and a lesion to any unit of the circuit abolishes the circadian nature of the sleep-wake cycle  [134]. The 
opponent-process model of sleep [135] states that the SCN driven arousal system opposes the homeostatic sleep 
load during the day. Then, the rising sleep load meets with a declining wakefulness drive (inhibition of arousal 
system) at the end of the subjective day, and the sleep gate is unlocked. This model holds SCN to be pivotal in 
the regulation of the sleep-wake cycle. To illustrate, the SCN-targeted deletion of the Clock or Cry gene causes a 
significant decline or increase in total sleep time, respectively [134]. Furthermore, a global deletion of clock genes 
causes fragmented sleep and aberrant switching between rapid eye movement (REM) and non-REM states. 

































































Additionally, a significantly large REM rebound is observed after sleep deprivation in canonical loss-of-function 
clock mutant Drosophila [136].
SCN also regulates the release of melatonin from pineal gland, and it, in turn, promotes sleep by suppressing the 
SCN’s neuronal activity through forming a positive feedback loop by activation of melatonin receptor 1 (MT1) 
[137]. A cluster of neurons in the lateral hypothalamus secrete orexin facilitated by multi-synaptic inputs from 
the SCN during the day time and propagate wakefulness [138]. Sleep-wake cycles also regulate the neuronal 
activity of the SCN [139], and thereby establishes a bilateral relationship between the circadian clock and sleep 
physiology (Fig 2). This relationship is apparent in the dramatic changes observed in clock gene expressions and 
electroencephalographic changes observed in the cerebral cortex of the sleep-deprived mice [140]. Sleep 
deprivation results in deleterious effects on chromatin remodeling mechanisms, which, in turn, modifies the 
binding of BMAL1: CLOCK dimer to its specific genes on the DNA and renders the TTFL arrhythmic [50]. 
Twenty-seven metabolites including serotonin, tryptophan, and taurine, as well as the markers of inflammation 
and neuronal injury, are significantly increased in blood plasma after sleep deprivation in humans [141, 142]. 
Mistimed and insufficient sleep also decreases the number of rhythmic genes in the human blood transcriptome 
[143, 144]. It is evident that the temporal alignment between the circadian phases and the sleep-wake cycle affects 
the individuals' quality of sleep as well as their health [145]. Misalignment of feeding cycles and sleep-wake 
cycles leads to uncoupling of TTFL in the SCN from that of hippocampus of mice leading to spatial memory 
deficits [130]. 
Furthermore, in vivo, two-photon imaging of awake and asleep mice revealed that sleep drives the clearance of 
neurotoxic metabolites from the brain by enhancing the convective exchange between the extracellular fluid and 
cerebrospinal fluid (CSF) [146]. The authors reported that the extracellular space is increased by 60% in asleep 
and anesthetized mice by promoting the convective flux. The glymphatic system promotes waste removal from 
the brain during sleep [147]. However the evidence of its relation with the circadian system is lacking. Briefly, 
the glymphatic system is a glial-based perivascular clearing system or a “pseudo” lymphatic system in the brain, 
and it transports soluble waste proteins and metabolites to the bonafide lymphatic system in the dural meninges 
and cranial nerves which are further drained into the deep cervical lymph nodes [148]. Furthermore, direct 
observations of the glymphatic system in humans have not been made, and considering the physiological 
differences between rodents and humans like brain mass, metabolic- and heart-rate, this research is still in its 
infancy.
Clinical evidence shows that nurses working the night shift routinely exhibit a disrupted REM/nREM sleep 
equilibrium, reduced total time spent in bed, and abrupt awakenings [149]. Sleep disturbances strongly correlate 
with the severity of cognitive symptoms in AD [6]. Piromelatine, a multimodal sleep drug is in phase II of clinical 
trials for AD therapy. Interestingly, AD patients experience protracted disruptions in their sleep-wake cycles that 
precede the onset of clinical symptoms. Chronic sleep disturbance - for four years - is associated with an increased 
risk of developing AD (OR = 1.23) and mortality (OR = 1.18) [150]. Sundowning syndrome in AD, is 
characterized by the worsening of cognitive and motor symptoms through the evening and night time, and it can 
be effectively treated by the circadian rhythm re-alignment with bright light therapy [151]. 

































































Furthermore, levels of circulating melatonin in the CSF and expression of its receptor MT1 in the SCN is also 
diminished in AD patients [152, 153]. Furthermore, chronotherapy with melatonin reduces total Aβ load by 
improving sleep quality in adjunction to its antioxidant effects [154, 155]. The release of melatonin from pineal 
gland is influenced by the SCN, and as discussed before, melatonin acts on MT1 receptors in the SCN to promote 
sleep. It may be possible that AD related SCN degeneration may contribute to melatonin dysregulation and 
potentiate sleep disturbances in AD patients. More studies are required to understand these dynamics. The 
concentrations of Aβ species in the CSF of the mice varies with the rest-activity cycle [156]. Sleep deprivation or 
infusion of orexin (wakefulness promoter) exacerbate the aggregation of Aβ peptides, which can be reversed by 
sleep-promoting orexin antagonists [157]. Collectively, these studies show a bilateral relationship between sleep 
deprivation and AD pathology, Fig 3.  
Insufficient sleep also affects the convective fluxes mentioned earlier in this section, and hinders the removal of 
neurotoxic waste products including Aβ42 from the mice brain [146], and thus promotes its aggregation. 
Significant suppression of waste removal by the glymphatic system has been observed in normally aged and 
APP/PS1 mice [158, 159]. Although a complete understanding of mechanisms of the glymphatic system such as 
physical forces propelling the solute transport is still in progress, it harbors the excellent potential for therapy of 
neurodegenerative disorders [160, 161]. In addition, histidine decarboxylase catalyzes the production of histamine 
in locus coereleus of the brain and regulat s sleep-wake cycles. A significant reduction in the expression of 
histidine decarboxylase mRNA is observed in AD patients [162]. These reports highlight the association between 
AD pathology and sleep-wake homeostasis which is directly controlled by the circadian clock.
6. Circadian rhythm in aging
More than 50% of the nuclear receptors that regulate metabolism (28 of 49) exhibit circadian oscillations in their 
mRNA expression [163]. The ROS load in a cell profoundly influences metabolism by restricting the redox 
reactions in a particular direction [164]. As emphasized before, redox states and the TTFL have a bilateral 
relationship, indicating that the dysfunction in one can adversely impact the other. Epigenetic-oxidized-redox-
shift theory of aging implies that a sedentary lifestyle causes a shift in redox balance towards an oxidized state 
that contributes to the mitochondrial damage and senility [165]. The levels of oxidized- cysteine and glutathione 
in human plasma were found to increase with aging [166]. 
Furthermore, Bmal1 deficient mice display a host of symptoms in their significantly short lifespan. The symptoms 
of Bmal1 KO mice involve premature cataracts, reduced subcutaneous adipose tissue, organ shrinkage, aberrant 
metabolism, and oxidative damage in various tissues [167]. These symptoms also depend on the timing of 
expression (or lack thereof) of Bmal1. Bmal1 deletion in adulthood results in brain astrogliosis and ocular 
abnormalities, however, it does not significantly affect life span, body weight, blood glucose levels, fertility, and 
age-dependent arthropathy [168]. Age-related suppression of Bmal1 expression also disrupts redox homeostasis 
in the cerebral cortex leading to oxidative damage facilitated neurodegeneration, as observed in Bmal1 KO mice 
[52]. Rhythmic expression of Clock and Bmal1 genes dampens and becomes desynchronized in the old mice 
brains [169]. Furthermore, Clock mutant mice are obese, hyperlipidemic, hyper-insulinemic, hyperglycemic, and 
steatotic [170]. Multi-unit neural activity in the SCN and sPVZ (primary output of the SCN) gradually declines 

































































with age [171]. Transplantation of fetal SCN in aged rats remarkably restores their circadian rhythms of body 
temperature, feeding, and activity [172]. 
CRd by forced phase shift induced by exposure to mistimed light increases mortality of the aged mice [173]. 
These pieces of evidence imply that CRd due to exogenous factors like mistimed feeding or light, and endogenous 
factors like redox dyshomeostasis or molecular dysfunction may contribute to aging. Specific molecules deeply 
embedded in circadian clock such as FOXO proteins, SIRT1, and melatonin are known for their critical roles in 
longevity [174, 175]. The mean levels of melatonin and cortisol decrease with age but their circadian patterns are 
altered differently with aging. Whereas the acrophase of melatonin shows a delay with increasing age, the 
acrophase of cortisol shows an advance. This indicates a weakened responsiveness of the circadian system in the 
elderly, and altered relationship between SCN and tissue-specific clocks driving these hormonal rhythms (pineal 
gland for melatonin and adrenal gland for cortisol)The levels of melatonin and cortisol are altered differently by 
aging, the acrophase of melatonin and cortisol rhythms show a positive and negative correlation repectively with 
age, indicating a weakened responsiveness of the circadian system in the elderly, and altered relationship between 
pacemakers driving these hormonal rhythms [176]. Since melatonin and cortisol are deeply rooted in the clock 
machinery, future investigations for their precise roles in aging are required to address these caveats.
7. Conclusion
Circadian rhythms are fundamental to all mammalian cells and are coupled by the SCN. CRd is typical in 
contemporary societies where light-noise, shift-work, and transmeridian travel are common. The scientific 
evidence suggests that the physiology of circadian clock - TTFL and non transcriptional osccilations - and its 
modulation by cellular signaling is adversely affected in AD. The dysregulation of these elements also contribute 
to the AD progression, and the result is a self-reinforcing vicious cycle. The present review presents a strong 
correlation between dysregulated elements of CR like Per, CLOCK, Bmal1, AVP with the cellular factors like 
SIRT1, FOXO, PRX, PK2 and ROR which may serve as putative pharmacological targets to restore circadian 
alignment for AD. Bright light therapy in conjunction with chronobiotics is beneficial for treating sundowning 
syndrome and other cognitive symptoms in advanced AD patients. Future investigations dissecting the role of 
circadian misalignment on the early stages of AD may provide key insights to design future preventive measures 
and therapeutics. 
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Figure 1: Transcriptional cog and metabolic cogs of the circadian clock. The schematic shows the cycles of TTFL 
and metabolic cog in the duration of a 24 hr day (left, daytime; right, nighttime). Both TTFL and metabolic cog 
cross-talk through mediators such as NAMPT, SIRT1, FOXO etc shown in space within the depiction of cogs. 
Note that transcription Per2 gene is also driven by CRE promoter. Solid black lines, transcription; blue arrows, 
the forward limb of the TTFL; red arrows, the negative limb of the TTFL; orange boxes, forward loop components; 
blue boxes, repressor components; red block arrows, oxidation; and blue block arrows, resolution. Abbreviations: 
BMAL1, brain and muscle ARNT-like protein; cAMP, cyclic adenosine monophosphate; CCG, clock-controlled 
genes; CK1, casein kinase 1; CLOCK, circadian locomotor output cycles kaput; CRY, cryptochrome; FOXO, 
forkhead box-O; NAD(P)H, nicotinamide adenine dinucleotide phosphate; NAMPT, nicotinamide 
phosphoribosyltransferase; NPAS2, neuronal PAS domain protein 2; PER, period; PRX, peroxiredoxins; ROR, 
retinoic acid-related orphan receptor; SIRT1, sirtuin 1; TTFL, transcription-translation feedback loop; βTrCP, the 
ubiquitin ligase scf complex.
Figure 2: Organization of circadian rhythms, the coupling of TTFL, metabolic cog, and sleep-wake cycle. The 
coupling of various cyclic processes is necessary for robust circadian clock. TTFL and redox cog cross-talk 
through various mediators which is also modulated by individual activities such as feeding, sleep and physical 
exercise. Abbreviations: CCG, clock-controlled genes; FOXO, forkhead box-O; NAMPT, nicotinamide 
phosphoribosyltransferase; SIRT1, sirtuin 1; TTFL, transcription-translation feedback loop.
Figure 3: A schematic of the putative pathways of AD onset by circadian rhythms dysfunction (CRd) and the 
intricate feedback loop between AD pathology and CRd depicted by the ouroboros symbol. The schematic shows 
a variety of physiological pathways that harmonize the circadian system, and pathological pathways that may 
contribute to AD pathology in the event of CRd and vice versa, forming a feedback loop. Blue lines represent the 
physiological pathways, and red lines represent the pathological pathways.  
Table 1: List of various components and regulators of the circadian clock, and their dysfunction in AD.

































































Transcriptional cog and metabolic cogs of the circadian clock. The schematic shows the cycles of TTFL and 
metabolic cog in the duration of a 24 hr day (left, daytime; right, nighttime). Both TTFL and metabolic cog 
cross-talk through mediators such as NAMPT, SIRT1, FOXO etc shown in space within the depiction of cogs. 
Note that transcription Per2 gene is also driven by CRE promoter. Solid black lines, transcription; blue 
arrows, the forward limb of the TTFL; red arrows, the negative limb of the TTFL; orange boxes, forward loop 
components; blue boxes, repressor components; red block arrows, oxidation; and blue block arrows, 
resolution. Abbreviations: BMAL1, brain and muscle ARNT-like protein; cAMP, cyclic adenosine 
monophosphate; CCG, clock-controlled genes; CK1, casein kinase 1; CLOCK, circadian locomotor output 
cycles kaput; CRY, cryptochrome; FOXO, forkhead box-O; NAD(P)H, nicotinamide adenine dinucleotide 
phosphate; NAMPT, nicotinamide phosphoribosyltransferase; NPAS2, neuronal PAS domain protein 2; PER, 
period; PRX, peroxiredoxins; ROR, retinoic acid-related orphan receptor; SIRT1, sirtuin 1; TTFL, 
transcription-translation feedback loop; βTrCP, the ubiquitin ligase scf complex. 
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Organization of circadian rhythms, the coupling of TTFL, metabolic cog, and sleep-wake cycle. The coupling 
of various cyclic processes is necessary for robust circadian clock. TTFL and redox cog cross-talk through 
various mediators which is also modulated by individual activities such as feeding, sleep and physical 
exercise. Abbreviations: CCG, clock-controlled genes; FOXO, forkhead box-O; NAMPT, nicotinamide 
phosphoribosyltransferase; SIRT1, sirtuin 1; TTFL, transcription-translation feedback loop. 
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A schematic of the putative pathways of AD onset by circadian rhythms dysfunction (CRd) and the intricate 
feedback loop between AD pathology and CRd depicted by the ouroboros symbol. The schematic shows a 
variety of physiological pathways that harmonize the circadian system, and pathological pathways that may 
contribute to AD pathology in the event of CRd and vice versa, forming a feedback loop. Blue lines represent 
the physiological pathways, and red lines represent the pathological pathways. 
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Table 1 List of various components and regulators of the circadian clock, and their dysfunction in the AD.
Component Role in circadian rhythm Variation/affect relevant to AD AD model References*
Decreased protein and mRNA expression Human [27, 28]
AVP, VIP Neurohumoral signaling from the SCN
Decreased neuronal secretion Mice [29]
Out of phase mRNA expression Human [41]
BMAL1 TTFL component Deletion causes astrogliosis and cognitive impairments, Aβ42 
decreases protein expression
Mice [52, 53, 54]
Overload and increased transients in neurons proximal to the plaques Mice [105, 106]Ca2+
Cellular signaling in circadian 
clock/entrainment Cytosolic load increases Aβ42 levels Rat [107]
CK1
TTFL component and post-translational 
regulation
Increased protein and mRNA expression Human [91]
FOXO3a Cellular signaling in circadian clock Induce Aβ42 dependent mitochondrial damage Rat [110]
Melatonin and its 
receptor MT1
Sleep-wake cycle Decrease Human [152, 153]
Orexin Propagates wakefulness Detrimental Mice [157]
Out of phase mRNA expression Human [41]
Deletion accelerates neurodegeneration and aging Drosophila [48]PER2 TTFL component
Diminished rhythms Mice [46]
































































PK2 and its receptor 
Prokr2
Neurohumoral signaling from the SCN Increased protein and mRNA expression, detrimental Rat [31]
PRX Marker of non-transcriptional rhythms Increased expression of PRX (1 & 2), decreased expression of PRX6 Human [65, 66]
PRX6
Overexpression accelerates Aβ induced memory loss, Bace1 
activation and oxidative stress
Mice [70]
SCN Master clock Decreased volume and neuronal density, astrogliosis Human [9, 27]
Decreased mRNA expression Human [93]
Overexpression decreases Aβ42 levels Mice [89]SIRT1
Histone modifications and post-
translational regulation
Overexpression decreased the hyperphosphorylated tau levels Primates [95]
* References are also cited in the text and numbered here according to its appearance in the text.
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